| 2025-12-10 |
详情>>
股本变动：
变动后总股本2793.87万股
变动原因 ▼▲
- 原因：
- Common Stock offered 1,353,469 shares by the company
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.68美元,归母净利润-4066.9万美元,同比去年增长-23.75%
|
| 2025-10-30 |
财报披露：
美东时间 2025-10-30 盘后发布财报
|
| 2025-10-14 |
股东大会：
将于2025-11-18召开股东大会
会议内容 ▼▲
- 1.To approve the repricing of certain outstanding stock options that have been granted under the Company’s 2017 Stock Incentive Plan (the “2017 Plan”), 2019 Stock Incentive Plan (the “2019 Plan”), and Second Amended and Restated 2021 Stock Incentive Plan (as may be amended, restated or otherwise modified from time to time in accordance with its terms, the “2021 Plan”), and together with the 2017 Plan and 2019 Plan, the “Plans”) (the “Option Repricing Proposal” or “Proposal 1”);
2.To approve a proposal to adjourn the Special Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of additional proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Repricing Proposal at the time of the Special Meeting (the “Adjournment Proposal” or “Proposal 2”);
3.To transact such other business as may properly come before the Special Meeting or any continuations, adjournments, and postponements thereof.
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-1.49美元,归母净利润-3419.7万美元,同比去年增长-64.64%
|
| 2025-06-28 |
复牌提示：
2025-06-27 12:26:41 停牌，复牌日期 2025-06-27 12:31:41
|
| 2025-05-09 |
股东大会：
将于2025-06-10召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.43美元,归母净利润-973.9万美元,同比去年增长11.66%
|
| 2025-04-21 |
股东大会：
将于2025-05-28召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
|
| 2025-03-27 |
详情>>
业绩披露：
2024年年报每股收益-2.11美元,归母净利润-4208.2万美元,同比去年增长-40.24%
|
| 2024-10-31 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.71美元,归母净利润-3286.4万美元,同比去年增长-52.15%
|
| 2024-09-30 |
详情>>
内部人交易：
Moss David J股份增加10000.00股
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-1.11美元,归母净利润-2077.1万美元,同比去年增长-59.32%
|
| 2024-05-29 |
股东大会：
将于2024-07-19召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024.
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.61美元,归母净利润-1102.5万美元,同比去年增长-68.68%
|
| 2024-03-28 |
详情>>
业绩披露：
2023年年报每股收益-1.67美元,归母净利润-3000.8万美元,同比去年增长-9.92%
|
| 2023-11-01 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.2美元,归母净利润-2160万美元,同比去年增长-0.62%
|
| 2023-08-07 |
详情>>
业绩披露：
2023年中报每股收益-0.73美元,归母净利润-1303.7万美元,同比去年增长5.12%
|
| 2023-04-21 |
股东大会：
将于2023-06-01召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023;
3.To approve an amendment to the Company’s 2021 Stock Incentive Compensation Plan (the “Plan”).
|
| 2022-04-19 |
股东大会：
将于2022-06-01召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-26 |
股东大会：
将于2021-06-01召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021;
3.To approve the INmune Bio, Inc. 2021 Stock Inventive Plan.
|
| 2020-08-21 |
股东大会：
将于2020-09-30召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2020;
|
| 2019-08-09 |
股东大会：
将于2019-09-12召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To approve the 2019 Equity Incentive Plan, including the reservation of two million (2,000,000) shares of common stock thereunder (the “Equity Plan Proposal”);
3.To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019;
4.To approve, for purposes of complying with applicable NASDAQ Listing Rules, the potential issuance and sale, in the Company’s sole discretion, of more than 20% of the Company’s common stock pursuant to the Company’s agreement with Lincoln Park Capital Fund LLC (“LPC”) pursuant to which LPC has agreed to purchase from the Company, from time to time, up to $20,000,000 of the Company’s common stock (the “LPC Transaction”) (the “LPC Nasdaq Proposal”);
5.To approve, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers (the “Say-on-Pay Proposal”);
6.To recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation paid to the Company’s named executive officers (the “Say-on-Frequency Proposal”);
7.To adjourn the Meeting to a later date or time, if necessary or appropriate, to solicit additional proxies in the event there are insufficient votes at the time of such adjournment to approve the Equity Issuance Proposal or the other proposals (the “Adjournment Proposal”).
|